Therefore, in this study, for the first time, we investigated the relative expression and co-expression and prognostic significance of all members of the HER family with EGFRvIII, and cancer stem cell biomarkers CD44 and CD109 in patients with GBM. This evidence concerns the gene CD109 and cancer.